Axillary Lymph Node Status After Completion of Preoperative Neoadjuvant Systemic Chemotherapy in Patients

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

April 30, 2010

Study Completion Date

May 31, 2010

Conditions
Invasive Breast Cancer
Interventions
PROCEDURE

Sentinel node mapping

Patients will undergo preoperative lymphoscintigraphy in the nuclear medicine department to access axillary and extra-axillary sites of localization. Intraoperatively, patients will also be injected with approximately 4 to 5 mL of 1% isosulfan blue dye (by intradermal, intraparenchymal, or subareolar route). Patients will undergo intraoperative identification and biopsy of all SLN candidates. A confirmatory axillary lymph node dissection will then be performed on all patients.

Trial Locations (1)

43210

Ohio State University, Columbus

All Listed Sponsors
lead

Stephen Povoski

OTHER

NCT00507611 - Axillary Lymph Node Status After Completion of Preoperative Neoadjuvant Systemic Chemotherapy in Patients | Biotech Hunter | Biotech Hunter